Clinical trial
Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery: A Phase III Multicenter Randomized Controlled Study
NCT01120405 is registered in ClinicalTrials.gov with Air Liquide Santé International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery: A Phase III Multicenter Randomized Controlled Study
- Lead sponsor
- Air Liquide Santé International
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- July 31, 2012
- Enrollment
- 600 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
coronary arteries disease risk, elevated cardiac risk